By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cancer Genetics, Inc. 

Meadows Office Complex
201 Route 17 North

2nd Floor
Rutherford  New York  07070  U.S.A.
Phone: 201-528-9200 Fax: 201-528-9201



Company News
Cancer Genetics (CGIX) Announces Second Quarter 2017 Financial Results, Accretive Acquisition And Capital Raise 8/15/2017 8:20:58 AM
Cancer Genetics (CGIX) Scoops Up vivoPharm for $12 Million 8/15/2017 5:57:59 AM
Cancer Genetics (CGIX) To Hold Second Quarter 2017 Earnings Call On Monday, August 14th 8/8/2017 1:21:52 PM
DIA Elects DIA’s John A. (Jay) Roberts As Chairman Of DIA Board Of Directors 8/3/2017 11:46:09 AM
Cancer Genetics (CGIX) Launches FDA-Approved Universal Companion Diagnostic For Lung Cancer Leveraging Thermo Fisher Scientific (TMO)'s Next Generation Sequencing Panel Oncomine Dx Target Test 6/27/2017 11:25:07 AM
Cancer Genetics (CGIX) Partners With Ventana Medical Systems (VMSI), A Member Of The Roche Group (RHHBY) To Ensure Market Access To Predictive Biomarker Test For New mmuno-Oncology (IO) Therapy For Advanced Bladder Cancer 5/15/2017 9:01:44 AM
Cancer Genetics (CGIX) Announces 15% Revenue Increase In First Quarter Of 2017 Over 2016 On Strong Organic Growth While Continuing On Path To Profitability 5/12/2017 8:38:05 AM
Cancer Genetics (CGIX) Changes The Paradigm For Lung Cancer Monitoring – Launches Clinically Actionable, Multi-Gene, Liquid Biopsy Test For Lung Cancer Patients, Liquid::Lung-CfDNA 5/8/2017 10:32:54 AM
Cancer Genetics (CGIX) To Hold First Quarter 2017 Earnings Call On Friday, May 12th 5/5/2017 9:03:16 AM
Cancer Genetics (CGIX) Launches A Unique, Industry-Leading Panel That Provides Comprehensive & Precise Information For Immuno-Oncology Therapy Assessment & Patient Monitoring 4/24/2017 10:50:06 AM